药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dioxaphetyl butyrate
Choline salicylate
Choline salicylate may increase the hypoglycemic activities of Ertugliflozin.
Dioxaphetyl butyrate
Carbaspirin calcium
Carbaspirin calcium may increase the hypoglycemic activities of Ertugliflozin.
Dioxaphetyl butyrate
Guacetisal
Guacetisal may increase the hypoglycemic activities of Ertugliflozin.
Dioxaphetyl butyrate
Aloxiprin
Aloxiprin may increase the hypoglycemic activities of Ertugliflozin.
Dioxaphetyl butyrate
Nitroaspirin
Nitroaspirin may increase the hypoglycemic activities of Ertugliflozin.
Dioxaphetyl butyrate
Trolamine salicylate
Trolamine salicylate may increase the hypoglycemic activities of Ertugliflozin.
Dioxaphetyl butyrate
Methyl salicylate
Methyl salicylate may increase the hypoglycemic activities of Ertugliflozin.
Dioxaphetyl butyrate
Phenyl aminosalicylate
Phenyl aminosalicylate may increase the hypoglycemic activities of Ertugliflozin.
Dioxaphetyl butyrate
Dersalazine
Dersalazine may increase the hypoglycemic activities of Ertugliflozin.
Dioxaphetyl butyrate
Clinafloxacin
The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Ertugliflozin.
Dioxaphetyl butyrate
Cibenzoline
The risk or severity of hypoglycemia can be increased when Cibenzoline is combined with Ertugliflozin.
Dioxaphetyl butyrate
Alaproclate
The risk or severity of hypoglycemia can be increased when Alaproclate is combined with Ertugliflozin.
Dioxaphetyl butyrate
Ritanserin
The risk or severity of hypoglycemia can be increased when Ritanserin is combined with Ertugliflozin.
Dioxaphetyl butyrate
Indalpine
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Ertugliflozin.
Dioxaphetyl butyrate
Dapoxetine
The risk or severity of hypoglycemia can be increased when Dapoxetine is combined with Ertugliflozin.
Dioxaphetyl butyrate
Mesterolone
Mesterolone may increase the hypoglycemic activities of Ertugliflozin.
Dioxaphetyl butyrate
Nandrolone
Nandrolone may increase the hypoglycemic activities of Ertugliflozin.
Dioxaphetyl butyrate
GLPG-0492
GLPG-0492 may increase the hypoglycemic activities of Ertugliflozin.
Dioxaphetyl butyrate
Nandrolone decanoate
Nandrolone decanoate may increase the hypoglycemic activities of Ertugliflozin.
Dioxaphetyl butyrate
Stanozolol
Stanozolol may increase the hypoglycemic activities of Ertugliflozin.